Keywords
parallel trade, pharmaceutical products, parallel import, anti-competitive agreements, pharmaceuticals
Abstract
Parallel trade of pharmaceutical products is a particularly interesting aspect of European competition law. The increasing role of parallel trade is also of significance to the producers of pharmaceuticals, as it results in the lowering of their profits. Due to the existence of parallel trade within the EU, the supervisory role of antitrust authorities and courts over competition law compliance is of essence. This article analyses anti-competitive agreements concerning the limitation of parallel trade and attempts to assess their legal and social status. Described is also one of the most relevant judgments of the European Court of Justice concerning this issue. The article closes with final conclusions and a critical insight into the issue of parallel trade limitation.
Recommended Citation
Nowakowski, M. (2014). Illegal agreements restricting parallel trade of pharmaceuticals in the light of EU competition law. internetowy Kwartalnik Antymonopolowy i Regulacyjny (internet Quarterly on Antitrust and Regulation), 3(3), 34-45. Retrieved from https://press.wz.uw.edu.pl/ikar/vol3/iss3/3
First Page
34
Last Page
45
Page Count
11
Publisher
University of Warsaw
